National Institute on Drug Abuse Keep your Brain Healthy - Keep your Body Healthy
Link to Home Page Link to About NIDA Link to Whats New Link to In the News Link to Publications Link to Spanish Publications Link to Funding Information
Go
Information for - see right links Student Information Index link Parent-Teacher Information Index link Researcher Information Index link


NIDA Home > Publications > Research Monographs >    

Hallucinogens: An Update



NIDA Research Monograph, Number 146 [Printed in 1994]


If you have the Acrobat reader plug-in for Netscape or Internet Explorer click on the document link and you will be able to view and/or print out the pages. If you have trouble viewing the document in your browser window, download the document (Windows users - right click on the link and Save as...) to your computer and get Adobe Acrobat Reader (free) in order to view it.


This monograph is not available by chapter. The Table of Contents (below) is shown to assist in locating information prior to downloading the monograph.

Download Monograph146.pdf - Hallucinogens: An Update (1.8 MB)


Table of Contents

Preface-----1
Geraline C. Lin

Classical Hallucinogens: An Introductory Overview-----4
Richard A. Glennon

Are Hallucinogens Psychoheuristic?-----33
Stephen Szára

Lysergamides Revisited-----52
Robert C. Pfaff, Xuemei Huang, Danuta Marona-Lewicka, Robert Oberlender, and David E. Nichols

Structure-Activity Relationships of Classic Hallucinogens and their Analogs-----74
Peyton Jacob III and Alexander T. Shulgin

Human Hallucinogenic Drug Research: Regulatory, Clinical, and Scientific Issues-----92
Rick J. Strassman

Serotonin Receptor Involvement in an Animal Model of the Acute Effects of Hallucinogens-----124
Mark A. Geyer and Kirsten M. Krebs

The Stimulus Effects of Serotonergic Hallucinogens in Animals-----157
Jerrold C. Winter

Electrophysiological Studies on the Actions of Hallucinogenic Drugs at 5-HT2 Receptors in Rat Brain-----183
George K. Aghajanian

Neurochemical Evidence That Hallucinogenic Drugs Are 5-HT1C Receptor Agonists: What Next?-----203
Elaine Sanders-Bush

Autoradiographic Approaches to Studying Hallucinogens or Other Drugs-----214
Nathan M. Appel

Hallucinogens Acting at 5-HT Receptors: Towards a Mechanistic Understanding at Atomic Resolution-----241
Harel Weinstein, Daqun Zhang, and Juan A. Ballesteros

Molecular Modeling of the Interaction of LSD and Other Hallucinogens with 5-HT2 Receptors-----263
Richard B. Westkaemper and Richard A. Glennon

Structure and Function of Serotonin 5-HT2 Receptors-----284
Jean C. Shih, Kevin Chen, and Timothy K. Gallaher

Summary-----298
Richard A. Glennon



Advanced Search | FAQs | Accessibility | Site Map | Help | NIDA Home | Privacy Policy | FOIA (NIH) | Employment |
National Institutes of Health logo Department of Health and Human Services Logo

The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Wednesday, September 18, 2002.